Price $8.04 |
Market Cap
63.4M
|
Sector Health Care |
Div. Growth
-
|
|
P/E
42.3
|
P/B
-
|
P/S
2.0
|
Dividend %
-
|
|
P/CF
-
|
P/FCF
12.8
|
Op. Cash Flow
6K
|
FCF
0.6
|
|
Op. Margin
13.80%
|
Net Margin
4.60%
|
ROE
-16.70%
|
ROI
94.90%
|
|
ROA
3.50%
|
EPS Growth
299.90%
|
Current Ratio
1.0
|
Debt/Equity
-
|
| Company | Price | P/E | Div. Yield | Market Cap ($Mil) | Rating |
|---|---|---|---|---|---|
| Champions Oncology Inc (CSBR) | $6.18 | - | - | 76.8M | Strong Buy |
| Apollo Endosurgery Inc (APEN) | $3.28 | - | - | 61.4M | Strong Buy |
| American Renal Associates Hold (ARA) | $7.14 | - | - | 240.3M | Strong Buy |
| Novelion Therapeutics Inc (USA (NVLN) | $0.69 | - | - | 12.8M | Strong Buy |
| MTBC Inc (MTBC) | $4.75 | - | - | 58.6M | Strong Buy |
Please note that all recommendations are based on our model's results and do not represent our personal opinion. The stock Rating process is purely mechanical.
All analysis relies on publicly available financial information. Learn More
